Talphera (NASDAQ:TLPH) Trading Down 1.5% – Here’s What Happened

Posted by Francis Steltz on Jul 25th, 2026

Talphera, Inc. (NASDAQ:TLPH – Get Free Report) dropped 1.5% during mid-day trading on Friday . The company traded as low as $1.3140 and last traded at $1.35. Approximately 89,522 shares were traded during trading, a decline of 80% from the average session volume of 441,854 shares. The stock had previously closed at $1.37.

Analysts Set New Price Targets

Several equities research analysts have commented on TLPH shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Talphera in a report on Friday, July 17th. Westpark Capital assumed coverage on Talphera in a report on Thursday, April 30th. They issued a “buy” rating and a $3.00 price objective for the company. Zacks Research upgraded Talphera to a “hold” rating in a research note on Monday, June 8th. Finally, HC Wainwright began coverage on Talphera in a report on Friday, June 5th. They set a “buy” rating and a $3.00 target price on the stock. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Talphera has an average rating of “Hold” and a consensus price target of $3.00.

Read Our Latest Stock Analysis on Talphera

Talphera Price Performance

The stock has a market capitalization of $70.06 million, a PE ratio of -4.35 and a beta of 0.70. The stock’s fifty day moving average is $1.03 and its 200-day moving average is $0.93.

Talphera (NASDAQ:TLPH – Get Free Report) last released its quarterly earnings data on Wednesday, May 13th. The company reported ($0.04) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.03. On average, analysts forecast that Talphera, Inc. will post -0.26 EPS for the current year.

Hedge Funds Weigh In On Talphera

A number of hedge funds have recently bought and sold shares of the business. Cantor Fitzgerald L. P. acquired a new stake in Talphera in the fourth quarter valued at approximately $658,000. Diadema Partners LP acquired a new position in shares of Talphera during the 4th quarter worth approximately $156,000. Renaissance Technologies LLC lifted its position in shares of Talphera by 412.6% during the 4th quarter. Renaissance Technologies LLC now owns 257,380 shares of the company’s stock valued at $293,000 after buying an additional 207,166 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Talphera by 107.0% during the 4th quarter. Geode Capital Management LLC now owns 342,987 shares of the company’s stock valued at $391,000 after buying an additional 177,294 shares in the last quarter. Finally, Nantahala Capital Management LLC grew its stake in Talphera by 75.3% in the 3rd quarter. Nantahala Capital Management LLC now owns 3,492,519 shares of the company’s stock valued at $3,120,000 after acquiring an additional 1,500,000 shares during the period. Hedge funds and other institutional investors own 37.67% of the company’s stock.

Talphera Company Profile

(Get Free Report)

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe.